158 related articles for article (PubMed ID: 8946203)
1. Correlations of allelic imbalance of chromosome 14 with adverse prognostic parameters in 148 renal cell carcinomas.
Béroud C; Fournet JC; Jeanpierre C; Droz D; Bouvier R; Froger D; Chrétien Y; Maréchal JM; Weissenbach J; Junien C
Genes Chromosomes Cancer; 1996 Dec; 17(4):215-24. PubMed ID: 8946203
[TBL] [Abstract][Full Text] [Related]
2. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
[TBL] [Abstract][Full Text] [Related]
3. Significance of chromosome arm 14q loss in nonpapillary renal cell carcinomas.
Herbers J; Schullerus D; Müller H; Kenck C; Chudek J; Weimer J; Bugert P; Kovacs G
Genes Chromosomes Cancer; 1997 May; 19(1):29-35. PubMed ID: 9135992
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity studies and deletion mapping identify two putative chromosome 14q tumor suppressor loci in renal oncocytomas.
Schwerdtle RF; Winterpacht A; Störkel S; Brenner W; Hohenfellner R; Zabel B; Huber C; Decker HJ
Cancer Res; 1997 Nov; 57(22):5009-12. PubMed ID: 9371493
[TBL] [Abstract][Full Text] [Related]
5. Positive correlation between allelic loss at chromosome 14q24-31 and poor prognosis of patients with renal cell carcinoma.
Kaku H; Ito S; Ebara S; Ouchida M; Nasu Y; Tsushima T; Kumon H; Shimizu K
Urology; 2004 Jul; 64(1):176-81. PubMed ID: 15245966
[TBL] [Abstract][Full Text] [Related]
6. Chromosome 14q LOH in localized clear cell renal cell carcinoma.
Mitsumori K; Kittleson JM; Itoh N; Delahunt B; Heathcott RW; Stewart JH; McCredie MR; Reeve AE
J Pathol; 2002 Sep; 198(1):110-4. PubMed ID: 12210070
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetic and molecular findings in 75 clear cell renal cell carcinomas.
Kardas I; Mrózek K; Babinska M; Krajka K; Hadaczek P; Lubinski J; Roszkiewicz A; Kuziemska E; Limon J
Oncol Rep; 2005 May; 13(5):949-56. PubMed ID: 15809763
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
9. Allelic losses at chromosome 17p in human renal cell carcinoma are inversely related to allelic losses at chromosome 3p.
Ogawa O; Habuchi T; Kakehi Y; Koshiba M; Sugiyama T; Yoshida O
Cancer Res; 1992 Apr; 52(7):1881-5. PubMed ID: 1348014
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity on the long arm of human chromosome 7 in sporadic renal cell carcinomas.
Shridhar V; Sun QC; Miller OJ; Kalemkerian GP; Petros J; Smith DI
Oncogene; 1997 Nov; 15(22):2727-33. PubMed ID: 9400999
[TBL] [Abstract][Full Text] [Related]
11. Characteristic loss of heterozygosity in chromosome 3P and low frequency of replication errors in sporadic renal cell carcinoma.
Chino K; Esumi M; Ishida H; Okada K
J Urol; 1999 Aug; 162(2):614-8. PubMed ID: 10411097
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non-papillary renal cell carcinomas.
Schullerus D; Herbers J; Chudek J; Kanamaru H; Kovacs G
J Pathol; 1997 Oct; 183(2):151-5. PubMed ID: 9390026
[TBL] [Abstract][Full Text] [Related]
13. PCR-based RFLP screening of the commonly deleted 3p loci in renal cortical neoplasms.
el-Naggar AK; Batsakis JG; Wang G; Lee MS
Diagn Mol Pathol; 1993 Dec; 2(4):269-76. PubMed ID: 7906993
[TBL] [Abstract][Full Text] [Related]
14. Delineation of a 2.8 megabases region harboring a potential tumor suppressor gene involved in renal cell carcinoma, that is commonly deleted from chromosome 14.
Gallou C; Méjean A; Bouvier R; Lucien F; Perennou M; Zindy PJ; Grifone R; Chrétien Y; Junien C; Béroud C
Anticancer Res; 2003; 23(6C):4865-70. PubMed ID: 14981937
[TBL] [Abstract][Full Text] [Related]
15. Allelic deletions in renal tumors: histopathological correlations.
Presti JC; Reuter VE; Cordon-Cardo C; Mazumdar M; Fair WR; Jhanwar SC
Cancer Res; 1993 Dec; 53(23):5780-3. PubMed ID: 8242636
[TBL] [Abstract][Full Text] [Related]
16. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
[TBL] [Abstract][Full Text] [Related]
17. Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification.
Hughson MD; Bigler S; Dickman K; Kovacs G
Mod Pathol; 1999 Mar; 12(3):301-9. PubMed ID: 10102616
[TBL] [Abstract][Full Text] [Related]
18. Thymidylate synthetase allelic imbalance in clear cell renal carcinoma.
Colavito D; Cartei G; Dal Bianco M; Stecca A; Zustovich F; Dalle Carbonare M; Ragazzi E; Farina M; Colombrino E; Leon A
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1195-200. PubMed ID: 19306093
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma.
Klatte T; Rao PN; de Martino M; LaRochelle J; Shuch B; Zomorodian N; Said J; Kabbinavar FF; Belldegrun AS; Pantuck AJ
J Clin Oncol; 2009 Feb; 27(5):746-53. PubMed ID: 19124809
[TBL] [Abstract][Full Text] [Related]
20. Loss of 14q31-q32.2 in renal cell carcinoma is associated with high malignancy grade and poor survival.
Alimov A; Sundelin B; Wang N; Larsson C; Bergerheim U
Int J Oncol; 2004 Jul; 25(1):179-85. PubMed ID: 15202004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
